Filing Details

Accession Number:
0001209191-12-022909
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-12 17:22:25
Reporting Period:
2012-04-11
Filing Date:
2012-04-12
Accepted Time:
2012-04-12 17:22:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276244 Shuster Mitchell Steiner 175 Toyota Plaza
7Th Floor
Memphis TN 38103
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-04-11 26,585 $3.51 1,994,123 No 4 S Indirect By Wife
Common Stock Disposition 2012-04-12 1,137 $3.50 1,992,986 No 4 S Indirect By Wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Wife
No 4 S Indirect By Wife
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,129,922 Direct
Common Stock 5,100 Indirect By Joint Account
Common Stock 134,210 Indirect By 2010 Trust
Common Stock 134,721 Indirect By Trust
Common Stock 133,981 Indirect By Trust
Common Stock 133,741 Indirect By Trust
Common Stock 133,741 Indirect By Trust
Footnotes
  1. An aggregate of 26,585 shares of common stock were sold in multiple trades on April 11, 2012 at prices ranging from $3.50 to $3.5209. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.